China NMPA Drug Inspection - Anhui Hongxin Pharmaceutical Development Co., Ltd. - Salt plantain
China NMPA drug inspection for Anhui Hongxin Pharmaceutical Development Co., Ltd. published September 29, 2020. Drug: Salt plantain. The Shaanxi Provincial Drug Administration released Bulletin Issue 9 of 2020 on September 29, 2020, following a series o
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA drug inspection for Anhui Hongxin Pharmaceutical Development Co., Ltd. published September 29, 2020. Drug: Salt plantain. The Shaanxi Provincial Drug Administration released Bulletin Issue 9 of 2020 on September 29, 2020, following a series o
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox